Dare Bioscience, Inc. Business Finance Contracts & Agreements

Form of Securities Purchase Agreement (August 2023) (Filed With SEC on August 30, 2023)

Form of Warrant (August 2023) (Filed With SEC on August 30, 2023)

Warrant Agreement to purchase shares of common stock of the registrant with Aquilo Partners, L.P., entered into as of October 16, 2016 (Filed With SEC on March 31, 2022)

Registration Rights Agreement, dated April 22, 2020, by and between Dar Bioscience, Inc. and Lincoln Park Capital Fund, LLC (Filed With SEC on April 23, 2020)

Purchase Agreement, dated April 22, 2020, by and between Dar Bioscience, Inc. and Lincoln Park Capital Fund, LLC (Filed With SEC on April 23, 2020)

Amendment No. 1 to Assignment Agreement entered into as of December 4, 2019 between Dar Bioscience, Inc. and Hammock Pharmaceuticals, Inc (Filed With SEC on March 27, 2020)

Underwriting Agreement dated as of April 9, 2019, by and between Dar Bioscience, Inc. and Roth Capital Partners, LLC, as the representative for the underwriters named therein (Filed With SEC on April 9, 2019)

Assignment Agreement by and between Dar Bioscience, Inc. and Hammock Pharmaceuticals, Inc. effective as of December 5, 2018 (Filed With SEC on April 1, 2019)

Form of Amendment to Warrant to Purchase Common Stock entered into as of June 27, 2018 (Filed With SEC on November 13, 2018)

Amendment No. 1 to Common Stock Sales Agreement, dated August 24, 2018, between Dar Bioscience, Inc. and H.C. Wainwright & Co., LLC (Filed With SEC on August 27, 2018)

Specimen stock certificate evidencing the shares of common stock (Filed With SEC on March 28, 2018)

Form of Warrant to Purchase Shares of Common Stock (Filed With SEC on February 13, 2018)

Underwriting Agreement, dated February 13, 2018, by and between Roth Capital Partners, LLC and the Registrant (Filed With SEC on February 13, 2018)

Common Stock Sales Agreement, dated January 4, 2018, by and between Dar Bioscience, Inc. and H.C. Wainwright & Co., LLC (Filed With SEC on January 4, 2018)

ASSET PURCHASE AGREEMENT (Filed With SEC on March 20, 2017)

CERULEAN PHARMA INC. (a Delawarecorporation) [] Shares of Common Stock UNDERWRITING AGREEMENT (Filed With SEC on March 30, 2015)

STOCK PURCHASE AGREEMENT (Filed With SEC on January 8, 2015)

LOAN AND SECURITY AGREEMENT (Filed With SEC on January 8, 2015)

WARRANT To Purchase Shares ofthe Common Stock of CERULEAN PHARMA INC. Dated as of January 8, 2015 (the Effective Date) (Filed With SEC on January 8, 2015)

AMENDMENT NO. 03 DatedSeptember 19, 2014 TO that certain Loan and Security Agreement No. 2161 dated as of December 6, 2011, as amended from time to time, (Agreement), by and... (Filed With SEC on November 13, 2014)

AMENDMENT TO STOCK OPTION AGREEMENT AND TERMINATION OF CONTINGENT CONSIDERATION AWARD (Filed With SEC on November 13, 2014)

CERULEAN PHARMA INC. 2014EMPLOYEE STOCK PURCHASE PLAN , 2014 (Filed With SEC on March 31, 2014)

CERULEAN PHARMA INC. (a Delawarecorporation) [] Shares of Common Stock FORM OF UNDERWRITING AGREEMENT (Filed With SEC on March 31, 2014)

PREFERRED STOCK PURCHASE WARRANT Shares of Series D Convertible Preferred Stock Subject to determination as set for the below CERULEAN PHARMA INC. Effective as of December 6, 2011... (Filed With SEC on March 10, 2014)

CERULEAN PHARMA INC. Stock Purchase Warrant (Filed With SEC on March 10, 2014)

WARRANT TO PURCHASE STOCK (Filed With SEC on March 10, 2014)

LOAN AND SECURITY AGREEMENT (Filed With SEC on March 10, 2014)

INDENTURE OF LEASE by and between RIVERTECH ASSOCIATES II, LLC (LESSOR) and CERULEANPHARMA INC. (LESSEE) RIVERSIDE TECHNOLOGY CENTER 840 Memorial Drive Cambridge, Massachusetts... (Filed With SEC on March 10, 2014)

SECOND SERIES D CONVERTIBLE PREFERRED STOCK PURCHASE AGREEMENT CERULEAN PHARMA INC. November 30, 2012 TABLE OF CONTENTS (Filed With SEC on March 10, 2014)

Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions. LICENSE AGREEMENT (Filed With SEC on March 10, 2014)